HLNCF
Price
$4.69
Change
-$0.33 (-6.57%)
Updated
Aug 14 closing price
Capitalization
43.62B
HLUBF
Price
$4.59
Change
-$0.15 (-3.16%)
Updated
Aug 11 closing price
Capitalization
5.86B
Interact to see
Advertisement

HLNCF vs HLUBF

Header iconHLNCF vs HLUBF Comparison
Open Charts HLNCF vs HLUBFBanner chart's image
HALEON
Price$4.69
Change-$0.33 (-6.57%)
Volume$927
Capitalization43.62B
H. Lundbeck A/S
Price$4.59
Change-$0.15 (-3.16%)
Volume$200
Capitalization5.86B
HLNCF vs HLUBF Comparison Chart in %
Loading...
HLNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLUBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HLNCF vs. HLUBF commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLNCF is a Hold and HLUBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (HLNCF: $4.82 vs. HLUBF: $4.59)
Brand notoriety: HLNCF and HLUBF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HLNCF: 34% vs. HLUBF: 23%
Market capitalization -- HLNCF: $43.62B vs. HLUBF: $5.86B
HLNCF [@Pharmaceuticals: Generic] is valued at $43.62B. HLUBF’s [@Pharmaceuticals: Generic] market capitalization is $5.86B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLNCF’s FA Score shows that 1 FA rating(s) are green whileHLUBF’s FA Score has 1 green FA rating(s).

  • HLNCF’s FA Score: 1 green, 4 red.
  • HLUBF’s FA Score: 1 green, 4 red.
According to our system of comparison, HLUBF is a better buy in the long-term than HLNCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLNCF’s TA Score shows that 4 TA indicator(s) are bullish while HLUBF’s TA Score has 1 bullish TA indicator(s).

  • HLNCF’s TA Score: 4 bullish, 3 bearish.
  • HLUBF’s TA Score: 1 bullish, 3 bearish.
According to our system of comparison, HLNCF is a better buy in the short-term than HLUBF.

Price Growth

HLNCF (@Pharmaceuticals: Generic) experienced а +0.73% price change this week, while HLUBF (@Pharmaceuticals: Generic) price change was -3.27% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +4.25%. For the same industry, the average monthly price growth was +10.98%, and the average quarterly price growth was +78.05%.

Industries' Descriptions

@Pharmaceuticals: Generic (+4.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLNCF($43.6B) has a higher market cap than HLUBF($5.86B). HLNCF has higher P/E ratio than HLUBF: HLNCF (21.25) vs HLUBF (8.31). HLUBF YTD gains are higher at: 3.612 vs. HLNCF (2.991). HLUBF has higher annual earnings (EBITDA): 4.25B vs. HLNCF (2.71B). HLUBF has more cash in the bank: 2.7B vs. HLNCF (676M). HLNCF has less debt than HLUBF: HLNCF (8.45B) vs HLUBF (15.2B). HLUBF has higher revenues than HLNCF: HLUBF (23B) vs HLNCF (11B).
HLNCFHLUBFHLNCF / HLUBF
Capitalization43.6B5.86B744%
EBITDA2.71B4.25B64%
Gain YTD2.9913.61283%
P/E Ratio21.258.31256%
Revenue11B23B48%
Total Cash676M2.7B25%
Total Debt8.45B15.2B56%
TECHNICAL ANALYSIS
Technical Analysis
HLNCFHLUBF
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
38%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
29%
Momentum
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
45%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
55%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
32%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
47%
Bullish Trend 2 days ago
33%
Advances
ODDS (%)
Bullish Trend 3 days ago
71%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
55%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
54%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
HLNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLUBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDEGX75.35N/A
N/A
Fidelity Growth Strategies
SGIGX34.62N/A
N/A
Steward Global Equity Income Fund R6
CDHRX35.94N/A
N/A
Calvert International Responsible Idx R6
PGSLX11.64N/A
N/A
Principal Global Listed Inf Inst
AIVSX65.22-0.03
-0.05%
American Funds Invmt Co of Amer A

HLNCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLNCF has been loosely correlated with HLN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HLNCF jumps, then HLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLNCF
1D Price
Change %
HLNCF100%
+2.77%
HLN - HLNCF
49%
Loosely correlated
+0.09%
SGIOF - HLNCF
21%
Poorly correlated
+13.16%
STEK - HLNCF
11%
Poorly correlated
+0.55%
EAPIF - HLNCF
11%
Poorly correlated
N/A
ZTS - HLNCF
10%
Poorly correlated
+0.69%
More

HLUBF and

Correlation & Price change

A.I.dvisor tells us that HLUBF and HLBBF have been poorly correlated (+18% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HLUBF and HLBBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLUBF
1D Price
Change %
HLUBF100%
N/A
HLBBF - HLUBF
18%
Poorly correlated
N/A
HLNCF - HLUBF
7%
Poorly correlated
+2.77%
ESAIY - HLUBF
5%
Poorly correlated
+2.73%
AKAN - HLUBF
2%
Poorly correlated
N/A
HLN - HLUBF
1%
Poorly correlated
+0.09%
More